October 12, 2016
Safety concerns blight promising cancer therapy
news@nature.com - Fetched: October 12th, 2016, 5:00am UTC
As the first T-cell therapies for tumours near US approval, researchers race to engineer less-toxic alternatives.
Nature 538 150 doi: 10.1038/538150a